XENIA PHARMA ApS

CVR number: 35529454
Vardegade 11, 2100 København Ø

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit-3.40-2.24-27.49-53.71-18.94
EBIT-3.40-2.24-27.49-53.71-18.94
Other financial income2.462.62
Other financial expenses-0.05-0.01-0.08
Pre-tax profit-3.45-2.24-27.50-51.32-16.32
Net earnings-3.45-2.24-27.50-51.32-16.32

Assets (kDKK)

20192020202120222023
Intangible assets total
Tangible assets total
Holdings in group member companies41.2741.27
Participating interests41.2741.2741.27
Investments total41.2741.2741.2741.2741.27
Long term receivables total
Inventories total
Short term receivables total
Cash and bank deposits1.241.501.900.71
Cash and cash equivalents1.241.501.900.71
Balance sheet total (assets)42.5142.7741.2743.1741.98

Equity and liabilities (kDKK)

20192020202120222023
Share capital80.0080.0080.0080.0080.00
Retained earnings-75.76-79.21-71.45-47.45-98.77
Profit of the financial year-3.45-2.24-27.50-51.32-16.32
Shareholders equity total0.79-1.45-18.95-18.77-35.09
Non-current liabilities total
Current loans from credit institutions11.13
Current owed to participating40.2444.2444.2461.74
Other non-interest bearing current liabilities41.723.974.8517.7015.33
Current liabilities total41.7244.2260.2261.9477.08
Balance sheet total (liabilities)42.5142.7741.2743.1741.98
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.